Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Symptom Cluster

glucose, (beta-d)-isomer has been researched along with Symptom Cluster in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's3 (37.50)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Britti, D; Caputi, AP; Cuzzocrea, S; De Sarro, A; Di Paola, R; Dugo, L; Genovese, T; Rossi, A; Sautebin, L; Sciarra, G; Serraino, I1
Chouker, A; Hoelzl, A; Hummel, T; Kaufmann, I; Peter, K; Schliephake, F; Thiel, M1
Goris, RJ; Hendriks, T; Huyben, CM; Jansen, MJ; Tax, WJ; van der Meer, JW1
Cook, DN; Kotwal, GJ; Miller, CG1
Shahan, TA; Simpson, J; Sorenson, WG1
Chi, EY; Fauci, AS; Harley, JB; Henderson, WR1
Leirisalo-Repo, M; Repo, H; Savilahti, E1
Basford, RE; Kaplan, SS; Kuhns, DB; Wechsler, HL; Zdziarski, UE1

Other Studies

8 other study(ies) available for glucose, (beta-d)-isomer and Symptom Cluster

ArticleYear
Role of 5-lipoxygenase in the multiple organ failure induced by zymosan.
    Intensive care medicine, 2004, Volume: 30, Issue:10

    Topics: Animals; Arachidonate 5-Lipoxygenase; Lipid Peroxidation; Male; Mice; Mice, Knockout; Models, Animal; Multiple Organ Failure; Nitric Oxide; Peritonitis; Random Allocation; Syndrome; Zymosan

2004
Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:3

    Topics: C-Reactive Protein; Calcimycin; Calcitonin; CD18 Antigens; Humans; Hydrogen Peroxide; Interleukin-6; Leukocyte Count; Middle Aged; Multiple Organ Failure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Opsonin Proteins; Phagocytosis; Protein Precursors; Sepsis; Severity of Illness Index; Shock, Septic; Syndrome; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Zymosan

2006
Increasing cytotoxic activity and production of reactive oxygen and nitrogen intermediates by peritoneal macrophages during the development of multiple organ dysfunction syndrome in mice.
    Scandinavian journal of immunology, 1996, Volume: 44, Issue:4

    Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Cytotoxicity, Immunologic; Disease Models, Animal; Inflammation; Macrophage Activation; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Nitric Oxide; Phagocytosis; Superoxides; Syndrome; Zymosan

1996
Two chemotactic factors, C5a and MIP-1alpha, dramatically alter the mortality from zymosan-induced multiple organ dysfunction syndrome (MODS): C5a contributes to MODS while MIP-1alpha has a protective role.
    Molecular immunology, 1996, Volume: 33, Issue:14

    Topics: Animals; Chemical and Drug Induced Liver Injury; Chemokine CCL3; Chemokine CCL4; Chemotactic Factors; Complement C5a; Female; Heart Diseases; Liver Diseases; Lung Diseases; Lymphatic Diseases; Macrophage Inflammatory Proteins; Male; Mice; Mice, Knockout; Multiple Organ Failure; Syndrome; Zymosan

1996
Cell wall preparations from environmental yeasts: effect on alveolar macrophage function in vitro.
    Annals of agricultural and environmental medicine : AAEM, 1998, Volume: 5, Issue:1

    Topics: Agricultural Workers' Diseases; Animals; Dose-Response Relationship, Drug; Dust; Leukotriene B4; Lung; Macrophages, Alveolar; Phagocytosis; Pneumonia; Rats; Rats, Sprague-Dawley; Sheep; Superoxides; Syndrome; Tumor Necrosis Factor-alpha; Yeasts; Zymosan

1998
Hypereosinophilic syndrome human eosinophil degranulation induced by soluble and particulate stimuli.
    British journal of haematology, 1988, Volume: 69, Issue:1

    Topics: Calcimycin; Cytoplasmic Granules; Eosinophilia; Eosinophils; Humans; Microscopy, Electron; Phagocytosis; Syndrome; Zymosan

1988
Aberrant phagocyte function in Shwachman syndrome.
    Clinical and experimental immunology, 1987, Volume: 69, Issue:1

    Topics: Agranulocytosis; Chemotaxis, Leukocyte; Child; Exocrine Pancreatic Insufficiency; Humans; Luminescent Measurements; Monocytes; Neutropenia; Neutrophils; Phagocytosis; Syndrome; Zymosan

1987
Increased plasma chemoattractant in Sweet's syndrome.
    Journal of the American Academy of Dermatology, 1985, Volume: 12, Issue:6

    Topics: Adult; Aspirin; Chemotaxis, Leukocyte; Dialysis; Hot Temperature; Humans; Isotretinoin; Leukocytosis; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentose Phosphate Pathway; Phagocytosis; Plasma; Skin Diseases; Syndrome; Tretinoin; Zymosan

1985